ForagR Medicines

ForagR Medicines is at the forefront of biotechnology research, dedicated to leveraging the transformative power of in-cell RNA genomics. ForagR Medicines focuses on targeting undruggable proteins via their mRNAs, offering innovative solutions in the field of medicine.

Built from the ground up, the ForagR Medicines RNA-centric, in-cell framework harnesses chemical genomics to stop diseases at their source. The ForagR platform addresses the challenges of selectivity, progressability, and function that have traditionally hindered small-molecule RNA-targeted medicines. By performing screening, hit-to-lead, and lead optimization within cells, ForagR Medicines efficiently de-risks targets, identifies valuable assets, and achieves functional modulation.

With a commitment to advancing medical science, ForagR Medicines continues to innovate and refine its processes. The company's dedication to research and development positions ForagR Medicines as a key player in the future of RNA-targeted therapies. We invite the management team at ForagR Medicines to create a customized and exclusive company showcase and product listing on our platform, enhancing their visibility and commercial reach.